Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Aurora Algae Expands Patent Portfolio, Accelerates Biotech Innovation

Published: Thursday, June 20, 2013
Last Updated: Thursday, June 20, 2013
Bookmark and Share
Company receives Notice of Allowance for U.S. Patent Application entitled “VCP-Based Vectors for Algal Cell Transformation.”

This allowed application adds to Aurora Algae’s existing patent portfolio, with 12 patent applications now either issued or allowed with the USPTO, and 30 additional applications pending in the United States.

The Aurora Algae patent portfolio covers inventions and improved processes spanning the end-to-end production of algae-based products, from strain development through cultivation, harvesting, extraction, processing, and product development.

“Our rigorous scientific research and development over the past decade has established Aurora Algae at the forefront of the emerging market for algae-based products,” explained Greg Bafalis, CEO of Aurora Algae. “By combining cutting-edge biotechnology with proprietary cultivation techniques, we are creating long-term alternatives to numerous unsustainable markets. Our expanding patent portfolio will play a major role in protecting our discoveries while we establish the foundation for a sustainable and profitable business.”

“Every day, we learn more about the incredible versatility of algae and its potential to address many of our modern global challenges, ranging from human health and nutrition to resource scarcity and alternative energy needs,” said Dr. Bertrand Vick, Cofounder and Chief Scientific Officer of Aurora Algae. “The newest technologies in our patent portfolio allow us to optimize specific desirable attributes of algae, such as oil content for biofuel, or omega-3 Essential Fatty Acid content for human nutrition. And as we refine our ability grow specialized strains for specific applications, the potential of this remarkable organism becomes even more compelling.”

Aurora Algae is also pursuing patent applications in multiple jurisdictions outside the United States, including Latin America, Europe, Australia, Asia, and the Middle East.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aurora Algae Appoints New CFO
Aurora Algae announced the appointment of Bill Roeschlein to the position of Chief Financial Officer.
Tuesday, January 29, 2013
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
New Mechanism of Plant RNA Degradation Identified
Researchers have identified a novel mechanism by which RNA is degraded.
Enlisting Insects to Protect Agriculture
New program aims for insect delivery of protective genes to modify mature plants within a single growing season.
New Model for Understanding Human Myeloma
Researchers develop mouse model where mice carry six human genes involved in human tumour growth.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Ethical Challenges of Genome Editing
A review of bioethics idnetifies two top challenges for genome editing.
Genetically Engineered Crops Are Safe
Study finds genetically engineered crop's risk to human health and the environment are no different than conventional crops.
Nimbolide Could Suppress Prostate Cancer Development
Oral administration of nimbolide over 12 weeks shows reduction of prostate tumour size and decrease in tumour metastasis.
Modified Yeast Shows Plant Response to Key Hormone
Researchers have developed a toolkit based on modified yeast to determine plant responses to auxin.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos